The peptide synthesis market size is calculated at USD 627.72 million in 2024 and is projected to surpass around USD 1,257.95 million by 2033 with a CAGR of 8.03%.
The global peptide synthesis market size was valued at USD 608.0 million in 2023 and is projected to grow at a CAGR of 12.7% from 2024 to 2030
USV Peptide is a leading peptide manufacturer company based in UK & USA. Manufacturing capabilities include custom peptide synthesis, cosmetic peptide, and peptides for phase 1/2/3 clinical trials.
The global peptide synthesis market size is estimated to grow from USD 2.8 billion in 2024 to USD 5.1 billion by 2035, representing a CAGR of 5.5% during the forecast period 2024-2035.
GenScript offers comprehensive peptide services, including custom peptide synthesis and high-throughput peptide libraries, with both research and cGMP-grade options. Leveraging the PepPower™ platfo...
The global peptide synthesis market growth is primed to transition from USD 601 million in 2023 to USD 859 million by 2028, showcasing a strong CAGR of 7.4%.
As a leading biotech company focusing exclusively on early drug discovery and development services, GenScript provides a comprehensive portfolio of services that include Bio-Reagent, Bio-Assay, Lead Optimization, and Antibody Drug Development.
Leading in peptide synthesis for over 20 years. Custom peptides, libraries, and pools with unmatched quality and modifications. Learn more here!
In 1993, Bio-Synthesis was one of the first peptide synthesis companies to acquire a Finnigan MALDI-TOF mass spectrometer for the accurate quality control of synthetic peptides produced in...
Innovative peptide synthesizers, high quality synthesis chemicals and a custom peptide synthesis services. Used by institutions worldwide.